Interactions between pharmacokinetics of paclitaxel, physical activity and body composition in breast cancer. Search for starting points to reduce dose limiting toxicities

Wuyts, S. (Contributor)
Adriaenssens, N. (Supervisor)
Beckwée, D. (Contributor)
Provyn, S. (Contributor)
Steurbaut, S. (Contributor)
de Haar-Holleman, A. (Contributor)
Lanckmans, K. (Contributor)
Jan Van Bocxlaer (Contributor)
An Vermeulen (Contributor)
Elke Gasthuys (Contributor)
Sofie Vande Casteele (Contributor)

Activiteit: Written proposal

Description

Written proposol for translational research project (Kom op tegen Kanker 2022)

Periode	24 jan 2024
Mate van erkenning	National

Gerelateerde inhoud

Onderzoeksoutput
Rethinking Chemotherapy Dosing: The impact of body composition, physical activity, and pharmacokinetics on dose-limiting toxicities in breast cancer patients.
Onderzoeksoutput: Poster
Dose-Limiting Toxicities of Paclitaxel in Breast Cancer Patients: Studying Interactions Between Pharmacokinetics, Physical Activity, and Body Composition—A Protocol for an Observational Cohort Study
Onderzoeksoutput: Article › peer review